Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute - Hainsworth, JD; Rubin, MS; Spigel, DR (J Clin Oncol, 2013)
et al.